A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation
Nurdan Taçyıldız, Gülsan Yavuz, Başak Adaklı Aksoy, Fikret Asarcıklı(Pediatric Oncology Group), Emel Ünal, Göksel Vatansever(Ankara University), Handan Dinçaslan(Pediatric Oncology Group), Hikmet Gülşah Tanyıldız(Ankara University)
Cited by 5
Related Papers
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
|The Lancet Oncology|2021|134
Successful treatment of central venous catheter infection due to <i>Candida lipolytica</i> by caspofungin‐lock therapy
|Mycoses|2011|35
Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children
|Nutrition and Cancer|2010|30
Retinoblastoma in Turkey: Results From a Tertiary Care Center in Ankara
|Journal of Pediatric Ophthalmology & Strabismus|2013|25